Current views on in vivo models for breast cancer research and related drug development.
Tiago FerreiraTiago AzevedoJéssica SilvaAna Isabel Faustino-RochaPaula Alexandra OliveiraPublished in: Expert opinion on drug discovery (2023)
models have limitations, and one of them is the fact that they do not fully mimic human diseases. Choosing the most suitable model for the study purpose is crucial for the development of new therapeutic agents that provide better care for breast cancer patients.